Innate immunity and cardiac allograft rejection

Kidney International

Volumn 78, Issue SUPPL. 119, 2010, Pages

  Millington, Timothy M ^a   Madsen, Joren C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

complement; heart transplant; innate immunity; natural killer cells; Toll like receptors

Indexed keywords

ANTIBODY; CD154 ANTIBODY; COMPLEMENT; CPG OLIGODEOXYNUCLEOTIDE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADAPTIVE IMMUNITY; BONE MARROW TRANSPLANTATION; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CHRONIC GRAFT REJECTION; COMPLEMENT SYSTEM; CONFERENCE PAPER; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HUMAN; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 78649649761     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.417     Document Type: Conference Paper

References (34)

1. Taylor D, StehlikJ, Edwards Let al. Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009. J Heart Lung Transplant 2009; 28: 1007-1022.
2. Schmauss D, Weis M. Cardiac allograft vasculopathy: recent developments. Circulation 2008; 117: 2131-2141.
3. Dresske B, Zhu X, Herwartz C et al. The time pattern of organ infiltration and distribution of natural killer cells and macrophages in the course of acute graft rejection after allogeneic heart transplantation in the rat. Transplant Proc 1997; 29: 1715.
4. Feng L, Ke N, Ye Z et al. Expression of NKG2D and its ligand in mouse heart allografts may have a role in acute rejection. Transplant Proc 2009; 41: 4332-4339.
5. Szot G, Zhou P, Rulifson I et al. Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice. Am J Transplant 2001; 1: 38-46.
6. Maier S, Tertilt C, Chambron N et al. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat Med 2001; 7: 557-562.
7. Kim J, Chang C, Hayden T et al. The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection. J Immunol 2007; 179: 6416-6420.
8. McNerney M, Lee K, Zhou P et al. Role of natural killer cell subsets in cardiac allograft rejection. Am J Transplant 2006; 6: 505-513.
9. Kitchens W, Uehara S, Chase C et al. The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 2006; 81: 811-817.
10. Kroemer A, Xiao X, Degauque N et al. The innate NK cells, allograft rejection, and a key role for IL-15. J Immunol 2008; 180: 7818-7826.
11. Uehara S, Chase C, Kitchens W et al. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J Immunol 2005; 175: 3424-3430.
12. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature 2009; 457: 557-561.
13. Cooper M, Elliott J, Keyel P et al. Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci USA 2009; 106: 1915-1919.
14. Fildes J, Bishop P, Mitchell J et al. 422: Natural killer cells deplete from peripheral blood and increase in myocardial tissue during acute rejection following heart transplantation. J Heart Lung Transplant 2008; 27: S212-S213.
15. Chao W. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol 2009; 296: H1-H12.
16. Gaudin P, Rayburn B, Hutchins G et al. Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients. Am J Surg Pathol 1994; 18: 338-346.
17. Shirali A, Goldstein D. Activation of the innate immune system by the endogenous ligand hyaluronan. Curr Opin Organ Transplant 2008; 13: 20-25.
18. Zou N, Ao L, Cleveland J et al. Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2008; 294: H2805-H2813.
19. Andrassy M, Volz H, Igwe JC et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008; 117: 3216-3226.
20. Yang J, Yang J, Ding J et al. Sequential expression of TLR4 and its effects on the myocardium of rats with myocardial ischemia-reperfusion injury. Inflammation 2008; 31: 304-312.
21. Cha J, Wang Z, Ao L et al. Cytokines link toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia. Ann Thorac Surg 2008; 85: 1678-1685.
22. Kaczorowski D, Nakao A, Mollen K et al. Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion. Transplantation 2007; 84: 1279-1287.
23. Methe H, Zimmer E, Grimm C et al. Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation 2004; 78: 1324-1331.
24. Porrett P, Yuan X, LaRosa D et al. Mechanisms underlying blockade of allograft acceptance by TLR ligands. J Immunol 2008; 181: 1692-1699.
25. Chen L, Wang T, Zhou P et al. TLR engagement prevents transplantation tolerance. Am J Transplant 2006; 6: 2282-2291.
26. Hamerman J, Ogasawara K, Lanier L. Cutting edge: toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J Immunol 2004; 172: 2001-2005.
27. Kloss M, Decker P, Baltz K et al. Interaction of monocytes with NK cells upon toll-like receptor-induced expression of the NKG2D ligand MICA. J Immunol 2008; 181: 6711-6719.
28. Hochweller K, Striegler J, Hämmerling G et al. A novel CD11c.DTR transgenic mouse for depletion of dendritic cells reveals their requirement for homeostatic proliferation of natural killer cells. Eur J Immunol 2008; 38: 2776-2783.
29. Keslar K, Rodriguez E, Tan C et al. Complement gene expression in human cardiac allograft biopsies as a correlate of histologic grade of injury. Transplantation 2008; 86: 1319-1321.
30. Pavlov V, Raedler H, Yuan S et al. Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection. J Immunol 2008; 181: 4580-4589.
31. Baldwin W, Samaniego-Picota M, Kasper E et al. Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation 1999; 68: 894-900.
32. Poelzl G, Ullrich R, Huber A et al. Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allograft vasculopathy. Transpl Int 2005; 18: 313-317.
33. Ferraresso M, Macor P, Valente M et al. Posttransplant ischemia-reperfusion injury in transplanted heart is prevented by a minibody to the fifth component of complement. Transplantation 2008; 86: 1445-1451.
34. Fildes J, Shaw S, Walker A et al. Mannose-binding lectin deficiency offers protection from acute graft rejection after heart transplantation. J Heart Lung Transplant 2008; 27: 1353-1356.